References:
1. Salvarani C, Crowson CS, O’Fallon WM, Hunder GG, Gabriel SE.
Reappraisal of the epidemiology of giant cell arteritis in Olmsted
County, Minnesota, over a fifty-year period. Arthritis Rheum.2004;51(2):264-268.
2. Nuenninghoff DM, Hunder GG, Christianson TJ, McClelland RL, Matteson
EL. Incidence and predictors of large-artery complication (aortic
aneurysm, aortic dissection, and/or large-artery stenosis) in patients
with giant cell arteritis: a population-based study over 50 years.Arthritis Rheum. 2003;48(12):3522-3531.
3. Erbel R, Aboyans V, Boileau C, et al. 2014 ESC Guidelines on the
diagnosis and treatment of aortic diseases: Document covering acute and
chronic aortic diseases of the thoracic and abdominal aorta of the
adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases
of the European Society of Cardiology (ESC). Eur Heart J.2014;35(41):2873-2926.
4. Gornik HL, Creager MA. Aortitis. Circulation.2008;117(23):3039-3051.
5. Kebed DT, Bois JP, Connolly HM, et al. Spectrum of Aortic Disease in
the Giant Cell Arteritis Population. Am J Cardiol.2018;121(4):501-508.
6. Kermani TA, Warrington KJ, Crowson CS, et al. Predictors of
Dissection in Aortic Aneurysms From Giant Cell Arteritis. J Clin
Rheumatol. 2016;22(4):184-187.
7. Zehr KJ, Mathur A, Orszulak TA, Mullany CJ, Schaff HV. Surgical
treatment of ascending aortic aneurysms in patients with giant cell
aortitis. Ann Thorac Surg. 2005;79(5):1512-1517.